Screener
Krystal Biotech, Inc. KRYS Japan — Product revenue, net
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Krystal Biotech, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 7:06 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001711279-26-000043
FAQ
- What is Krystal Biotech, Inc.'s japan — product revenue, net?
- Krystal Biotech, Inc. (KRYS) reported japan — product revenue, net of $8.19M in Q1 2026.
- What does japan — product revenue, net mean?
- This metric represents the total net revenue generated from the sale of pharmaceutical products within the Japanese market. It reflects the company's commercial success and market penetration in this specific geographic region after accounting for returns, allowances, and discounts. This figure is critical for assessing the regional performance of the company's gene therapy portfolio and its ability to navigate local regulatory and reimbursement landscapes.
Ask your AI about Krystal Biotech, Inc.'s japan — product revenue, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude